{"id":7213,"date":"2005-07-14T08:40:58","date_gmt":"2005-07-14T07:40:58","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=7213"},"modified":"2014-05-21T17:26:02","modified_gmt":"2014-05-21T17:26:02","slug":"pfizer-discontinues-development-of-capravirine","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/7213","title":{"rendered":"Pfizer discontinues development of capravirine"},"content":{"rendered":"<p><strong>On July 1 Pfizer announced that it has discontinued clinical development of capravirine, an NNRTI with activity against NNRTI-resistant HIV, that was in phase 2 development. This came as no surprise given the complicated drug interactions that make it difficult to use with other PIs or NNRTIs.<\/strong><\/p>\n<p>Results reported earlier this year at the 12th Annual Conference on Retroviruses and Opportunistic Infections (CROI) indicated no benefit compared to placebo.<\/p>\n<p>Source: Pfizer PR<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On July 1 Pfizer announced that it has discontinued clinical development of capravirine, an NNRTI with activity against NNRTI-resistant HIV, that was in phase 2 development. This came as no surprise given the complicated drug interactions that make it difficult &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-7213","post","type-post","status-publish","format-standard","hentry","category-antiretrovirals"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=7213"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7213\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=7213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=7213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=7213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}